Survodutide (BI 456906) is a dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim. The glucagon component increases energy expenditure while GLP-1 provides appetite suppression. Phase 2 trials showed up to 19% weight loss, particularly effective for fatty liver disease
Survodutide 10 mg – 10 Vials
$310.00
Kit of 10 Vials – For Research Use Only – Not Intended for Human Consumption
Extra Features
- Premium Quality
- Secure Payments
- Satisfaction Guarantee
- Worldwide Shipping
- Money Back Guarantee
Be the first to review “Survodutide 10 mg – 10 Vials”
Reviews
There are no reviews yet.